Skip to main content

Want a detailed portfolio tracker?

Charles River Laboratories International (CRL) Market Cap (2000 - 2026)

Charles River Laboratories International (CRL) market cap from Jun 23, 2000 to Jun 2, 2026. The current Charles River Laboratories International (CRL) market cap is $8.41B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Charles River Laboratories International (CRL) Market Cap CAGR table

PeriodCAGR
1 Year TTM-8.03%
3 Years TTM-8.45%
5 Years TTM-7.54%
10 Years TTM+9.19%
All Time TTM+8.02%

Annual Market Cap change of Charles River Laboratories International (CRL)

YearMarket CapChange
2026$8.41B-14.31%
2025$9.82B+4.00%
2024$9.44B-22.15%
2023$12B+9.38%
2022$11B-41.71%
2021$19B+52.96%
2020$12B+66.34%
2019$7.48B+37.01%
2018$5.46B+5.34%
2017$5.18B+43.65%
2016$3.61B-3.95%
2015$3.75B+24.64%
2014$3.01B+19.41%
2013$2.52B+41.34%
2012$1.78B+31.32%
2011$1.36B-32.25%
2010$2.01B-9.62%
2009$2.22B+75.87%
2008$1.26B-60.18%
2007$3.17B+52.14%
2006$2.08B+2.08%
2005$2.04B-7.91%
2004$2.22B+34.02%
2003$1.65B-10.78%
2002$1.85B+14.93%
2001$1.61B+22.28%
2000$1.32BN/A

Comparison Charles River Laboratories International (CRL) market cap with competitors

Charles River Laboratories International (CRL) market cap is $8.41B.

TickerNameMarket CapUpside
TMOThermo Fisher Scientific Inc$169.71B+1917.16%
DHRDanaher Corp$122.58B+1356.94%
IDXXIdexx Laboratories Inc$43.66B+418.94%
WATWaters Corp$33.59B+299.25%
AAgilent Technologies Inc$32.76B+289.43%
NTRANatera Inc$28.99B+244.58%
IQVIQVIA Holdings Inc$27.65B+228.63%
MTDMettler-Toledo International Inc$23.36B+177.67%
ILMNIllumina Inc$22.35B+165.65%
DGXQuest Diagnostics Inc$21.35B+153.79%
LHLaboratory Corp Of America Holdings$21.25B+152.60%
EXASExact Sciences Corp$20.02B+137.92%
GHGuardant Health Inc$16.77B+99.32%
MEDPMedpace Holdings Inc$12.22B+45.29%
RVTYRevvity Inc$10.80B+28.42%
ICLRIcon Plc$9.07B+7.80%
QGENQiagen NV$7.46B-11.38%
SHCSotera Health Company$4.43B-47.38%
RDNTRadnet Inc$4.23B-49.74%
BLLNBilliontoone Inc - Class A$4.18B-50.31%
TWSTTwist Bioscience Corp$3.99B-52.59%
VCYTVeracyte Inc$3.55B-57.81%
OLKOlink Holding AB (publ)$3.24B-61.46%
GRALGRAIL Inc$2.94B-65.08%
ADPTAdaptive Biotechnologies Corp$2.21B-73.73%
WGSGeneDx Holdings Corp - Class A$1.43B-83.00%
CDNACaredx Inc$1.14B-86.49%
PSNLPersonalis Inc$993.52M-88.19%
OPKOpko Health Inc$986.54M-88.27%
CSTLCastle Biosciences Inc$644.09M-92.34%
FLGTFulgent Genetics Inc$516.43M-93.86%
MYGNMyriad Genetics Inc$370.99M-95.59%
PREPrenetics Global Ltd - Class A$276.75M-96.71%
NEONeogenomics Inc$251.93M-97.01%
IMDXInsight Molecular Diagnostics Inc$206.95M-97.54%
BDSXBiodesix Inc$149.69M-98.22%
FONRFonar Corp$130.50M-98.45%
XGNExagen Inc$120.68M-98.57%
BNRBurning Rock Biotech Ltd$64.43M-99.23%
PRPOPrecipio Inc$42.01M-99.50%
MDXHMDxHealth SA$37.52M-99.55%
MYNZMainz Biomed N.V.$28.66M-99.66%
MBAICheckCap Ltd$11.93M-99.86%
XWELXWELL Inc$10.94M-99.87%
CHEKCheck-Cap Ltd$9.42M-99.89%
NOTVInotiv Inc$9.32M-99.89%
BIAFBioAffinity Technologies Inc$7.42M-99.91%
NDRAENDRA Life Sciences Inc$6.65M-99.92%
ADVBAdvanced Biomed Inc$5.36M-99.94%
APDNApplied Dna Sciences Inc$3.21M-99.96%
FRESFresh2 Group Limited$2.97M-99.96%
ISPCiSpecimen Inc$1.23M-99.99%
PRPHProPhase Labs Inc$415412.05-100.00%